TLPH Q2 2025 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q2 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$4M

Net Income

-$3M

EPS (Diluted)

$-0.10

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$166,000

Balance Sheet

Total Assets

$17M

Total Liabilities

$10M

Stockholders' Equity

$7M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$2M	+100.0%
Operating Income	-$4M	-$4M	+13.5%
Net Income	-$3M	-$4M	+8.8%